
Mark Zuckerberg, the Chief Executive of Meta Platforms, has announced the launch of a new product group centered on generative artificial intelligence (AI).
This move by Meta Platforms not only signals increased investment in AI but is also an indication that they are looking to capitalize on the growing demand for AI-powered products.
As the tech industry continues to face slowing growth and job cuts, Artificial Intelligence (AI) has emerged as a bright spot for investments.
Read more: Big Tech Calls On EU Not To Regulate General Purpose Artificial Intelligence
“We’re starting by pulling together a lot of the teams working on generative AI across the company into one group focused on building delightful experiences around this technology,” Zuckerberg said in an Instagram post.
“Over the longer term, we’ll focus on developing AI personas that can help people in a variety of ways,” Zuckerberg said, but for now “we’re exploring experiences with text (chat in WhatsApp and Messenger), with images (creative Instagram filters and ad formats), and with video and multi-modal experiences.”
The new product team will report to Chris Cox, Meta’s chief product officer, a company spokesperson confirmed. This will enable Meta to more rapidly implement the AI research team’s findings in Meta’s products, the spokesperson said.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas